811 related articles for article (PubMed ID: 29594337)
1. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
2. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F
Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770
[TBL] [Abstract][Full Text] [Related]
4. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
[TBL] [Abstract][Full Text] [Related]
5. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
[TBL] [Abstract][Full Text] [Related]
6. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
Yıldırım-Buharalıoğlu G
Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
[TBL] [Abstract][Full Text] [Related]
7. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
[TBL] [Abstract][Full Text] [Related]
8. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
[TBL] [Abstract][Full Text] [Related]
9. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
[TBL] [Abstract][Full Text] [Related]
11. Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
Zhang W; Cheng J; Diao P; Wang D; Zhang W; Jiang H; Wang Y
Br J Cancer; 2020 Feb; 122(4):528-538. PubMed ID: 31848446
[TBL] [Abstract][Full Text] [Related]
12. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
[TBL] [Abstract][Full Text] [Related]
13. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
[TBL] [Abstract][Full Text] [Related]
14. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
[No Abstract] [Full Text] [Related]
15. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P
Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576
[TBL] [Abstract][Full Text] [Related]
16. Jumonji domain containing-3 (JMJD3) inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo.
Jun Z; Xinmeng J; Yue L; Zhi W; Yan Z; Tieyi Y; Jiangan T
Inflamm Res; 2020 Jul; 69(7):657-666. PubMed ID: 32394143
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase KDM6B regulates human podocyte differentiation
Guo Y; Xiong Z; Guo X
Biochem J; 2019 Jun; 476(12):1741-1751. PubMed ID: 31138771
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of the histone demethylase inhibitor GSK-J4 in chondrosarcomas.
Lhuissier E; Aury-Landas J; Allas L; Boittin M; Boumediene K; Baugé C
IUBMB Life; 2019 Nov; 71(11):1711-1719. PubMed ID: 31241814
[TBL] [Abstract][Full Text] [Related]
19. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress.
Hong BJ; Park WY; Kim HR; Moon JW; Lee HY; Park JH; Kim SK; Oh Y; Roe JS; Kim MY
Cancer Res; 2019 Nov; 79(22):5849-5859. PubMed ID: 31506334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
